Literature DB >> 15743836

Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Megan E Baldwin1, Michael M Halford, Sally Roufail, Richard A Williams, Margaret L Hibbs, Dianne Grail, Hajime Kubo, Steven A Stacker, Marc G Achen.   

Abstract

Vascular endothelial growth factor receptor 3 (Vegfr-3) is a tyrosine kinase that is expressed on the lymphatic endothelium and that signals for the growth of the lymphatic vessels (lymphangiogenesis). Vegf-d, a secreted glycoprotein, is one of two known activating ligands for Vegfr-3, the other being Vegf-c. Vegf-d stimulates lymphangiogenesis in tissues and tumors; however, its role in embryonic development was previously unknown. Here we report the generation and analysis of mutant mice deficient for Vegf-d. Vegf-d-deficient mice were healthy and fertile, had normal body mass, and displayed no pathologic changes consistent with a defect in lymphatic function. The lungs, sites of strong Vegf-d gene expression during embryogenesis in wild-type mice, were normal in Vegf-d-deficient mice with respect to tissue mass and morphology, except that the abundance of the lymphatics adjacent to bronchioles was slightly reduced. Dye uptake experiments indicated that large lymphatics under the skin were present in normal locations and were functional. Smaller dermal lymphatics were similar in number, location, and function to those in wild-type controls. The lack of a profound lymphatic phenotype in Vegf-d-deficient mice suggests that Vegf-d does not play a major role in lymphatic development or that Vegf-c or another, as-yet-unknown activating Vegfr-3 ligand can compensate for Vegf-d during development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743836      PMCID: PMC1061605          DOI: 10.1128/MCB.25.6.2441-2449.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer.

Authors:  L Jansen; M H Doting; E J Rutgers; J de Vries; R A Olmos; O E Nieweg
Journal:  Br J Surg       Date:  2000-07       Impact factor: 6.939

2.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

Authors:  M J Karkkainen; R E Ferrell; E C Lawrence; M A Kimak; K L Levinson; M A McTigue; K Alitalo; D N Finegold
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers.

Authors:  S A Stacker; K Stenvers; C Caesar; A Vitali; T Domagala; E Nice; S Roufail; R J Simpson; R Moritz; T Karpanen; K Alitalo; M G Achen
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

4.  Prox1 function is required for the development of the murine lymphatic system.

Authors:  J T Wigle; G Oliver
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

5.  Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis.

Authors:  M G Achen; R A Williams; M P Minekus; G E Thornton; K Stenvers; P A Rogers; F Lederman; S Roufail; S A Stacker
Journal:  J Pathol       Date:  2001-02       Impact factor: 7.996

6.  Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis.

Authors:  H Kubo; T Fujiwara; L Jussila; H Hashi; M Ogawa; K Shimizu; M Awane; Y Sakai; A Takabayashi; K Alitalo; Y Yamaoka; S I Nishikawa
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

7.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

Authors:  S A Stacker; C Caesar; M E Baldwin; G E Thornton; R A Williams; R Prevo; D G Jackson; S Nishikawa; H Kubo; M G Achen
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

8.  Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

Authors:  S J Mandriota; L Jussila; M Jeltsch; A Compagni; D Baetens; R Prevo; S Banerji; J Huarte; R Montesano; D G Jackson; L Orci; K Alitalo; G Christofori; M S Pepper
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

9.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Authors:  T Mäkinen; L Jussila; T Veikkola; T Karpanen; M I Kettunen; K J Pulkkanen; R Kauppinen; D G Jackson; H Kubo; S Nishikawa; S Ylä-Herttuala; K Alitalo
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

10.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Authors:  M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

View more
  79 in total

Review 1.  The lymphatic system in health and disease.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

2.  VEGF-D: a modifier of embryonic lymphangiogenesis.

Authors:  Terhi Karpanen; Kari Alitalo
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

Review 3.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

Review 4.  Receptor tyrosine kinase-mediated angiogenesis.

Authors:  Michael Jeltsch; Veli-Matti Leppänen; Pipsa Saharinen; Kari Alitalo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 5.  Lymphatics in lung disease.

Authors:  Souheil El-Chemaly; Stewart J Levine; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

6.  Existence of the lymphatic system in the primate corpus luteum.

Authors:  Fuhua Xu; Richard L Stouffer
Journal:  Lymphat Res Biol       Date:  2009       Impact factor: 2.589

7.  Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.

Authors:  Terhi Karpanen; Maria Wirzenius; Taija Mäkinen; Tanja Veikkola; Hidde J Haisma; Marc G Achen; Steven A Stacker; Bronislaw Pytowski; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

8.  Nuclear localization of vascular endothelial growth factor-D and regulation of c-Myc-dependent transcripts in human lung fibroblasts.

Authors:  Souheil El-Chemaly; Gustavo Pacheco-Rodriguez; Daniela Malide; Victor Meza-Carmen; Jiro Kato; Ye Cui; Philip I Padilla; Arun Samidurai; Bernadette R Gochuico; Joel Moss
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

9.  Vasculogenesis and Angiogenesis in VEGF Receptor-1 Deficient Mice.

Authors:  Vivienne C Ho; Guo-Hua Fong
Journal:  Methods Mol Biol       Date:  2015

Review 10.  Potential therapeutic strategies for lymphatic metastasis.

Authors:  Bernadette M M Zwaans; Diane R Bielenberg
Journal:  Microvasc Res       Date:  2007-09-19       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.